Headline
The latest stories from AHA Today.
President Biden nominated Chiquita Brooks-LaSure to lead the Centers for Medicare & Medicaid Services. Brooks-LaSure previously served as deputy director for policy at the Center for Consumer Information and Insurance Oversight within CMS and earlier at the Department of Health and Human…
To help combat burnout and fatigue amidst the COVID-19 pandemic’s effects on health care workers’ wellbeing, the International Hospital Federation and the International Society for Quality in Health Care are hosting a Feb. 23 conference that will share good practices and innovations on how…
President Biden told a group of G-7 leaders that the U.S. will support the COVAX alliance tasked with distributing COVID-19 vaccines to 92 low- and middle-income countries.
The Centers for Medicare & Medicaid Services has identified Healthcare Common Procedure Coding System codes for billing Medicare for the combination monoclonal antibodies bamlanivimab and etesevimab, made by Eli Lilly and Co.
The AHA recently launched a new webpage dedicated to disseminating accessible information focused on addressing the equity issues in COVID-19 testing, treatment and vaccine administration efforts.
Safety monitoring during the first month of the COVID-19 national vaccination program shows “reassuring safety profiles” for the Pfizer and Moderna COVID-19 vaccines, the Centers for Disease Control and Prevention reported.
The Centers for Medicare & Medicaid Services extended until March 22 its guidance limiting the hospital survey process during the COVID-19 public health emergency.
3M recently released guidance to help customers identify fraudulent surgical respirators in response to growing reports of fraud related to three of its respirator models.
The AHA today expressed support for the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, which allows for the temporary reciprocity for treatment by medical professionals licensed in one state to patients in other states.
Advancing health equity within communities of color disproportionately impacted by COVID-19 — and getting the facts straight about reasons for hesitancy over receiving vaccines — are priority issues for government policy influencers and health care organization leaders.